FDA Mulls Renaming Rockfish: Fishermen, Weigh In on Labels!
Published Date: 4/1/2026
Notice
Summary
The FDA wants to hear from fishermen, seafood sellers, and fish lovers about possibly changing the official market names for certain rockfish species. This update aims to make fish labels clearer and safer for everyone, with comments open until May 1, 2026. If the name changes happen, it could affect how these fish are sold and marketed, so your input matters!
Analyzed Economic Effects
6 provisions identified: 0 benefits, 4 costs, 2 mixed.
Different Species, Different Food Hazards
FDA notes rockfish (Sebastes spp.) have parasite risks that require cooking or freezing, while some species called "snapper" carry ciguatera toxin risks—mixing names could cause processors to apply the wrong hazard controls and potentially harm consumers. FDA is seeking comments on how to avoid food safety risks if names change.
Allergen Labeling Risk from Name Changes
Finfish are a major food allergen and the law requires the specific fish be identified by its common or usual name on labels (sections 201(qq) and 403(w) of the FD&C Act). FDA warns that changing the acceptable market name for rockfish could cause allergic consumers to inadvertently eat rockfish if labels use a different name, and it reminds manufacturers they must still comply with allergen labeling rules.
FDA Reviewing Rockfish Market Names
The FDA is considering changing the official market name for 18 Sebastes (rockfish) species after Congress directed review in Public Law 119-37, Section 777 (enacted November 2025). FDA is asking for data and public comment on potential new names and related guidance, with comments due May 1, 2026.
Name Change Could Alter Market Value
Industry stakeholders have requested switching some rockfish names to terms like "snapper" to increase economic value, and FDA is asking for data on economic impacts if rockfish were labeled with another species' market name or a new name. FDA specifically requests evidence about economic or other impacts of any name change.
Labeling and HACCP Compliance Costs
FDA asks how changes to the acceptable market name for rockfish would affect Hazard Analysis and Critical Control Point (HACCP) plans, labeling, and recordkeeping and requests estimated compliance costs for industry to update these systems. If names change, processors and sellers may need to revise HACCP plans and labels, which could require time and expense.
Current Misbranding Rules and Legal Risk
Under current FDA policy, labeling Sebastes species as "snapper" in interstate commerce would be considered false or misleading and misbranded under section 403(a)(1) of the FD&C Act; FDA also treats only Lutjanus campechanus as lawful to sell as "red snapper." Any name change could require updates to The Seafood List and prohibited vernacular names.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2026-06293, Non-Refillable Steel Cylinders From China; Institution of Five-Year Reviews
The U.S. is checking if special taxes on non-refillable steel cylinders from China should stay or go. This affects companies that make or sell these cylinders and could impact prices or jobs. If you’re interested, you’ve got until May 1, 2026, to share your thoughts, so don’t miss out!
Next: 2026-06297, Implementing Section 927 Waiver Process for Certain Unmanned Aircraft Operations
The FAA is rolling out a new waiver process to help drone operators fly in ways that don’t fit current rules. This change makes it easier and faster for certain unmanned aircraft to get permission without jumping through complicated hoops. Starting now, affected drone pilots can apply for these waivers, saving time and possibly money while keeping the skies safe.